Answers are grounded in this paper and cite their sources.
The strategy of moderate-to-deep sedation based on remimazolam tosilate is safe and effective in bronchoscopic examination and treatment. When combined with 0.1 μg/kg sufentanil, the ED50 and the ED95 of remimazolam tosilate are 0.174 mg/kg and 0.219 mg/kg, respectively.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: